ARCHIVES

Large Studies Show Promising Results For Targeted Therapies Alimta, Tarceva

This article is from The Cancer Letter archive.

Vol. 32 No. 6 | June 26, 2009

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Survey Predicts Year 2000 Survival of 66%

April 3, 1987

NIH Priority To Pay 4,000 Grants, Send Summary Statements

February 2, 1996

Shubik Group Finally Completes Document On Carcinogenicity Criteria

March 12, 1976

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

April 1, 2005

Senate Authorizes $30 Million For Childhood Cancer Clinical Trials Research.

July 18, 2008

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997